Ventilator-associated pneumonia. Diagnosis, pathogenesis and prevention.
Ventilator-associated pneumonia is common, difficult to diagnose, affects the most vulnerable of patients and carries a high mortality. During prolonged mechanical ventilation the oropharynx, sinuses, dentition and stomach of critically ill patients become colonised with pathogenic bacteria. Colonised secretions pool in the oropharynx and subglottic space. These secretions repeatedly gain access to the lower airways by leakage past the tracheal tube cuff. If host defence mechanisms are overwhelmed, multiplication occurs in the lower respiratory tract producing an inflammatory response in the bronchioles and alveoli. The inflammatory response is characterised by capillary congestion, leucocyte and macrophage infiltration and fibrinous exudation into the alveolar spaces. If this inflammatory response occurs more than 48 h after intubation, it is called ventilator-associated pneumonia. Prevention depends on reducing upper airway and gastrointestinal reservoirs of bacteria, reducing or abolishing aspiration of these bacteria past the tracheal tube cuff and enhancing bacterial clearance from the lower airways.
Young
P J
PJ
Critical Care Complex, Norfolk and Norwich Acute NHS Trust, Norwich, UK.
Ridley
S A
SA
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D006801:Humans; D018410:Pneumonia, Bacterial / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control; D012121:Respiration, Artificial / Q000009:adverse effects*
D000900:Anti-Bacterial Agents